Berkshire Asset Management LLC Vertex Pharmaceuticals Inc Transaction History

Berkshire Asset Management LLC

$2 Billion
Q2 2024

A detailed history of Berkshire Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Berkshire Asset Management LLC holds 4,403 shares of VRTX stock, worth $2.21 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,403

Previous 4,789 8.06%

Holding current value

$2.21 Million

Previous $2 Million 3.1%

% of portfolio

0.1%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $1.73 Million - $2.14 Million	4,403 New	4,403 $2.06 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $31,392 - $34,348	-77 Reduced 1.58%	4,789 $2 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $7,889 - $9,445	-23 Reduced 0.47%	4,866 $1.98 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $16,570 - $17,760	-49 Reduced 0.99%	4,889 $1.7 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $39,302 - $43,988	125 Added 2.6%	4,938 $1.74 Million
Q1 2023 Jun 06, 2023	BUY	$283.23 - $323.1 $1.36 Million - $1.56 Million	4,813 New	4,813 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $318,190 - $355,025	-1,162 Reduced 18.95%	4,969 $1.44 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $262,920 - $327,363	-1,119 Reduced 15.43%	6,131 $1.73 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $604,919 - $712,970	-2,732 Reduced 27.37%	7,250 $1.89 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $36,287 - $45,807	-205 Reduced 2.01%	9,982 $2.19 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $11,790 - $13,194	-65 Reduced 0.63%	10,187 $1.85 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $222,363 - $262,224	-1,186 Reduced 10.37%	10,252 $2.07 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $854,785 - $996,368	4,129 Added 56.49%	11,438 $2.46 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $939,411 - $1.25 Million	4,538 Added 163.77%	7,309 $1.73 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $92,034 - $109,116	360 Added 14.93%	2,771 $754,000
Q2 2020 Aug 12, 2020	SELL	$225.48 - $295.8 $600,904 - $788,307	-2,665 Reduced 52.5%	2,411 $700,000
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $661,438 - $820,498	3,311 Added 187.59%	5,076 $1.21 Million
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $8,168 - $10,971	-49 Reduced 2.7%	1,765 $386,000
Q2 2019 Jul 29, 2019	BUY	$164.61 - $190.37 $57,778 - $66,819	351 Added 23.99%	1,814 $333,000
Q4 2018 Jan 24, 2019	SELL	$151.91 - $192.21 $60,764 - $76,884	-400 Reduced 21.47%	1,463 $242,000
Q4 2017 Jan 17, 2018	SELL	$137.28 - $155.55 $3,569 - $4,044	-26 Reduced 1.38%	1,863 $279,000
Q3 2017 Oct 30, 2017	BUY	$148.13 - $162.24 $279,817 - $306,471	1,889	1,889 $287,000

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.

Account

Berkshire Asset Management LLC Vertex Pharmaceuticals Inc Transaction History